LACK OF EFFECT OF HALOPERIDOL OR METHAMPHETAMINE TREATMENT ON THE MESSENGER-RNA LEVELS OF 2 DOPAMINE D(2)-RECEPTOR ISOFORMS IN RAT-BRAIN

被引:0
作者
SORA, I
FUJIWARA, Y
TOMITA, H
ISHIZU, H
AKIYAMA, K
OTSUKI, S
YAMAMURA, HI
机构
[1] OKAYAMA UNIV,SCH MED,DEPT NEUROPSYCHIAT,2-5-1 SHIKATA CHO,OKAYAMA 700,JAPAN
[2] UNIV ARIZONA,ARIZONA HLTH SCI CTR,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724
[3] ZIKEI INST PSYCHIAT,OKAYAMA,JAPAN
来源
JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY | 1992年 / 46卷 / 04期
关键词
DOPAMINE D(2)-RECEPTOR; MESSENGER RNA; INSITU HYBRIDIZATION; ALTERNATIVE SPLICING; HALOPERIDOL; METHAMPHETAMINE;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In order to investigate whether changes of the two mRNAs encoding the D2 receptor isoforms were induced by chronic haloperidol or methamphetamine treatment in rats, we measured the brain mRNA levels using in situ hybridization histochemistry (ISHH). We used two oligonucleotide probes, an ''insert'' probe to hybridize with the longer D2 receptor, D2(444), mRNA, and a ''spanning'' probe to hybridize with the shorter D2 receptor, D2(415), mRNA. Both D2 mRNAs were detected by ISHH in the caudate putamen, nucleus accumbens, substantia nigra, pars compacta and ventral tegmental area. The distributions and the amounts of the mRNAs for the two D2 isoforms did not change after chronic administration of haloperidol (1 mg/kg/day for 14 days, ip) or methamphetamine (4 mg/kg/day for 14 days, ip). These results suggest that the changes of D2 receptor density induced by chronic neuroleptic and psychostimulant treatment are not due primarily to receptor expression.
引用
收藏
页码:967 / 973
页数:7
相关论文
共 29 条
  • [1] AKIYAMA K, 1982, BIOL PSYCHIAT, V17, P223
  • [2] DIFFERENTIAL PLASTICITY OF THE DOPAMINERGIC-D2 RECEPTOR MESSENGER-RNA ISOFORMS UNDER HALOPERIDOL TREATMENT, AS EVIDENCED BY INSITU HYBRIDIZATION IN RAT ANTERIOR-PITUITARY
    ARNAULD, E
    ARSAUT, J
    DEMOTESMAINARD, J
    [J]. NEUROSCIENCE LETTERS, 1991, 130 (01) : 12 - 16
  • [3] DOPAMINE D2-RECEPTOR MESSENGER-RNA IS DIFFERENTIALLY REGULATED BY DOPAMINERGIC AGENTS IN RAT ANTERIOR AND NEUROINTERMEDIATE PITUITARY
    AUTELITANO, DJ
    SNYDER, L
    SEALFON, SC
    ROBERTS, JL
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1989, 67 (01) : 101 - 105
  • [4] BOYSON SJ, 1986, J NEUROSCI, V6, P3177
  • [5] CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA
    BUNZOW, JR
    VANTOL, HHM
    GRANDY, DK
    ALBERT, P
    SALON, J
    CHRISTIE, MJ
    MACHIDA, CA
    NEVE, KA
    CIVELLI, O
    [J]. NATURE, 1988, 336 (6201) : 783 - 787
  • [6] CHARUCHINDA C, 1987, J NEUROSCI, V7, P1352
  • [7] A 2ND MOLECULAR-FORM OF D2 DOPAMINE RECEPTOR IN RAT AND BOVINE CAUDATE-NUCLEUS
    CHIO, CL
    HESS, GF
    GRAHAM, RS
    HUFF, RM
    [J]. NATURE, 1990, 343 (6255) : 266 - 269
  • [8] CHANGES IN RAT STRIATAL DOPAMINE TURNOVER AND RECEPTOR ACTIVITY DURING ONE YEARS NEUROLEPTIC ADMINISTRATION
    CLOW, A
    THEODOROU, A
    JENNER, P
    MARSDEN, CD
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 63 (2-3) : 135 - 144
  • [9] INCREASE IN STRIATAL DOPAMINE D2-RECEPTOR MESSENGER-RNA AFTER LESIONS OF HALOPERIDOL TREATMENT
    COIRINI, H
    SCHUMACHER, M
    ANGULO, JA
    MCEWEN, BS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) : 369 - 371
  • [10] CREESE I, 1980, HDB PSYCHOPHARMACOLO, V17, P81